Medtech recalls 108,000 tins of Sucrets; Mission Pharmacal buys transdermal patch maker;

> Fresenius Kabi is recalling 5,488 bags of Kabiven 3.9% lipid emulsion over labeling issues. Notice

> Medtech Pharma is recalling 107,832 tins of Insight Pharmaceuticals' Sucrets lozenges over labeling issues. Notice

> Mylan ($MYL) is recalling 7,722 bottles of mycophenolic acid delayed-release tablets that failed specifications for dissolution. Notice

> San Antonio,TX-based Mission Pharmacal has acquired for an undisclosed sum the assets of transdermal patch maker, Miami, FL-based ProSolus Pharmaceuticals. Release

And Finally... Canada has gotten drugs and ingredients from nearly 300 foreign drug facilities that have self inspected or been inspected by consultants they hired. Story

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.